The findings support the view that RHBDF1 overexpression, as it is often observed in clinic breast cancer tissues, may facilitate the loss of apicobasal polarity in mammary gland epithelial cells during early stages of breast tumorigenesis. Here, RHBDF1 is linked to breast cancer.